$-0.18
(Market cap
$9,659 Mln
Recently Viewed
Clear AllMarket cap
$9,659 Mln
Revenue (TTM)
$11,244 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
2.9 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-957 Mln
ROE
-0.1 %
ROCE
-5.2 %
Industry P/E
--
EV/EBITDA
22.4
Debt to Equity
1.6
Book Value
$11.9
EPS
$-1.9
Face value
--
Shares outstanding
516,252,514
CFO
$19,550.00 Mln
EBITDA
$20,409.00 Mln
Net Profit
$14,393.00 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Baxter International (BAX)
| -4.2 | 13.4 | -7.1 | -35.8 | -26.1 | -26.9 | -8.2 |
|
BSE Sensex*
| -8.3 | 4.2 | -5.6 | -2.4 | 9.2 | 10.1 | 11.6 |
|
S&P Midcap 400
| 8.6 | 10.3 | 4.0 | 35.6 | 13.3 | 6.0 | 9.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Baxter International (BAX)
| -34.5 | -24.4 | -24.2 | -40.6 | 8.5 | -3.0 | 28.4 |
|
S&P Midcap 400
| 5.9 | 12.1 | 14.4 | -14.5 | 23.2 | 11.8 | 24.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Baxter International (BAX)
|
18.3 | 9,659.1 | 11,244.0 | -957.0 | -1.9 | -14.6 | -- | 1.5 |
| 91.7 | 168,225.1 | 45,134.0 | 6,276.0 | 15.4 | 24.6 | 26.7 | 3.2 | |
| 196.1 | 13,612.3 | 4,035.0 | 410.4 | 14.2 | 10.4 | 33.6 | 3.3 | |
| 300.8 | 7,890.9 | 2,583.2 | 759.9 | 25.2 | 10.8 | 10.5 | 1.0 | |
| 95.0 | 12,546.1 | 2,938.9 | 537.9 | 18.3 | 12.3 | 23.7 | 2.8 | |
| 78.1 | 9,045.6 | 13,184.0 | 398.0 | 5.2 | 12 | 23.7 | 2.7 | |
| 483.6 | 166,649.2 | 10,064.7 | 2,856.0 | 29.3 | 16.7 | 59.5 | 9.1 | |
| 28.2 | 27,139.1 | 17,834.0 | 895.0 | 8.5 | 7.8 | 26.2 | 2.1 | |
| 138.8 | 5,764.2 | 1,992.7 | -905.6 | -2.3 | -24.5 | 98.7 | 1.8 | |
| 514.0 | 191,756.6 | 44,556.0 | 6,737.0 | 19.5 | 13.1 | 29.1 | 3.7 |
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.... It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois. Read more
Chairman of the Board, President & CEO
Mr. Jose E. Almeida
Executive VP, CFO & Interim Chief Accounting Officer
Mr. Joel T. Grade
Headquarters
Deerfield, IL
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Baxter International Inc (BAX) is $18.31 (NYSE) as of 22-Apr-2026 16:00 EDT. Baxter International Inc (BAX) has given a return of -26.06% in the last 3 years.
Since, TTM earnings of Baxter International Inc (BAX) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-10.26
|
1.60
|
|
2024
|
-22.91
|
2.14
|
|
2023
|
7.38
|
2.33
|
|
2022
|
-10.62
|
4.43
|
|
2021
|
33.89
|
4.79
|
The 52-week high and low of Baxter International Inc (BAX) are Rs 32.59 and Rs 15.73 as of 23-Apr-2026.
Baxter International Inc (BAX) has a market capitalisation of $ 9,659 Mln as on 17-Apr-2026. As per SEBI classification, it is a Mid Cap company.
Before investing in Baxter International Inc (BAX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.